Belimumab
- IVBelimumabBenlysta
 
Mechanism of Action
- A human monoclonal antibody to B lymphocyte stimulator (BLyS, also known as BAFF), a member of the TNF family that inhibits B cell apoptosis and stimulates differentiation of B cells.
 
Clinical Use
Indications
- Antibody-positive systemic lupus erythematosus (SLE).
 
- Adverse Effects
 - Hypersensitivity reactions
 - Infections
 - Nausea / vomiting / diarrhoea